Target intelligence / Profile preview

Medial vestibular nucleus (MVN)

Target
MVN
Molecular classification
Other
01

Overview

The Medial vestibular nucleus (MVN) is a prominent anatomical structure located in the floor of the fourth ventricle within the medulla and pons (StatPearls, 2023). It serves as a primary relay station for sensory information originating from the semicircular canals of the inner ear, playing a fundamental role in the vestibulo-ocular reflex (VOR) to maintain visual stability during head motion (Wikipedia, 2024). Beyond gaze stabilization, the MVN contributes to vestibulospinal pathways that regulate posture and balance (NIH, 2022). Pathological changes or imbalances in neuronal activity within the MVN are central to the pathophysiology of vestibular disorders such as vertigo and motion sickness (PubMed, 2021). Pharmacological intervention typically involves the use of vestibular suppressants that target various receptors (e.g., H1, mAChR, GABA-A) expressed on MVN neurons to dampen overactive signaling and alleviate symptoms (Journal of Vestibular Research, 2020). The MVN is also involved in the integration of multisensory inputs, including visual and proprioceptive information, to provide a coherent sense of spatial orientation (NIH, 2022).

Other names
Schwalbe's nucleusNucleus vestibularis medialisMedial nucleus of the vestibular nerve
02

Mechanism of action

Vestibular suppressants act by modulating neurotransmitter systems within the nucleus, including histaminergic (H1), cholinergic (muscarinic), and GABAergic pathways, to reduce the firing rate and excitability of vestibular neurons (StatPearls, 2023; PubMed, 2021).

03

Biological functions

Vestibulo-ocular reflex (VOR)Gaze stabilizationPostural controlHead movement processingSpatial orientationOther
04

Disease associations

VertigoMotion sicknessMeniere's diseaseVestibular neuritisLabyrinthitisNystagmusOther
05

Safety considerations

SedationDrowsinessCognitive impairmentIncreased risk of fallsAnticholinergic side effects (dry mouth, blurred vision)Potential for dependency (with benzodiazepines)
06

Interacting drugs

Meclizine

5 more in the full profile.

07

Biomarkers

NystagmusCaloric reflex testVestibular evoked myogenic potentials (VEMP)Video head impulse test (vHIT)

Beyond the preview

Go deeper on Medial vestibular nucleus (MVN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medial vestibular nucleus (MVN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call